RG ADHD in Childhood and Adolescence
Vice Chairman of the Department, Registrar, Head of the Research Group
Phone: +49 621 1703-4521, 4522
Fax: +49 621 1703-4525
Main Medical Building, 1st Floor, Room 149
Andrea Morawetz, Phone: +49 (0) 621 1703-4522, Fax: -4525, e-mail
Sevim Gezgin, Phone: +49 (0) 621 1703-4504, Fax: -4525, E-Mail
Main Medical Building, 3d Floor, Room 381
Attention-Deficit/Hyperactivity Disorder (ADHD) is one of the most common psychiatric disorders in children and adolescents. Besides attentional problems, the affected children suffer from a significant hyperactivity beyond the age-typical level ,and increased impulsivity. This can cause substantial limitations in the fields of learning and performance (at school), but also in families, and social interactions with peers. The RG focuses on the genetic and environmental causes of the syndrome, the neurobiological associations, and the resulting treatment options.
Especially, ESCAlife-study has to be mentioned, funded by the German Federal Ministry of Education and Research, a national-wide study with the aim to investigate stepped-care and evidence-based therapeutic interventions for patients with ADHD between the age of three and 45 years. Further information of the ESCAlife study is provided here: www.esca-life.org. In addition, the RG ADHD is involved in studies of the effectiveness of biofeedback methods on ADHD core symptoms and the reward system, respectively (in collaboration with the RG Developmental Clinical Neurophysiology in Childhood and Adolescence). A further research area is the field of affective dysregulation in children and adolescents regarding epidemiological, neurobiological and therapeutic aspects, investigated in the ADOPT-study.
Furthermore, the RG ADHD played a pivotal role in writing and implementing the S3 German guideline for the diagnosis and therapy of children, adolescents, and adults with ADHD.
ADHD Special Outpatient Clinic
With the newly established ADHD special outpatient clinic, our range of services for the treatment of children and adolescents with ADHD has been expanded. This now ranges from comprehensive ADHD diagnostics, to telephone-supported self-help guidance for parents, to medication and/or intensive behavioural therapy.
This ensures treatment in line with guidelines, depending on the severity of ADHD. New research results and concepts for the treatment of children and adolescents with ADHD from our ESCAlife study are also incorporated.
If you are interested, please contact us by e-mail.
Your contact persons:
Marie-Therese Steiner, Child and Adolescent Psychotherapist (VT), e-mail
see accordion below
Phone: +49 621 1703-4911
Zentralinstitut für Seelische Gesundheit (ZI) - https://www.zi-mannheim.de